Delivery Order SPE2DB20D3101-SPE2DB25FRCV4

Award Date 2/25/25
Potential Completion Date 3/18/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $17,378.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a completion date of November 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,951.86 firm fixed-price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a ceiling value of $19,759.30. This is a firm fixed price delivery order contract with a period of performance through March 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,494.06 firm fixed-price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication, with a ceiling value of $17,378.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This is a $12,613.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of SOMATULINE DEPOT 60 MG/0.2 ML 0.2ML, a specialty medication. The contract has a period of performance through March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $9,654.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Somatuline Depot 60 mg/0.2 ml, a specialty medication, with an ultimate completion date of August 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,686.67, is for the delivery of SOMATULINE DEPOT 90 MG/0.3 ML 0.3ML, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 3, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,585.64 delivery order contract is for the provision of the prescription drug Somatuline Depot 120 mg/0.5 ml, with a period of performance through June 4, 2024. Amerisourcebergen, a subsidiary of the Cencora, Inc. corporate group, was selected for this...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $23,711.16 firm fixed price delivery order is for the specialty medication Somatuline Depot 120 mg/0.5 ml, with a performance period through February 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRCV4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,903.74 firm fixed price delivery order is for the supply of SOMATULINE DEPOT 120 MG/0.5 ML 0.5ML, a specialty medication.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

In addition to the DLA IDC, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/27/25, 9:56 AM